Opendata, web and dolomites

Symptoma SIGNED

Symptoma, Better Diagnosis for Patients with Rare and Complex Diseases

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Symptoma project word cloud

Explore the words cloud of the Symptoma project. It provides you a very rough idea of what is the project "Symptoma" about.

suffer    decades    list    shown    30    misdiagnoses    pushing    rate    capitalize    learning    causes    health    spent    receive    paradigm    outdone    delivering    20k    right    ranging    spot    attain    errors    medicine    care    patient    profit    446    don    leaves    err    mission    symptoma    first    search    blind    free    cognitively    societal    dealing    competitive    time    deaths    40    750    pay    diagnostic    overcoming    had    asking    save    willingness    overwhelm    advantage    opportunity    engine    proceeded    bar    sorted    intelligence    persist    diseases    healthcare    continue    unmet    customers    budgets    22    wait    harm    pilot    satisfied    human    diagnosis    reducing    doctors    enter    decision       rare    companies    business    globally    demonstrated    unacceptable    patients    delayed    barriers    probability    settings    matching    solution    questions    billion    million    lives    counteracting    tools    com    total    technological    solving    language    inaccurate    quality    devastating    deep    wasted    demand    diagnoses    misdiagnosis    competitors    cognitive    10    accuracy    symptoms   

Project "Symptoma" data sheet

The following table provides information about the project.

Coordinator
SYMPTOMA GMBH 

Organization address
address: NEUHOFEN 5
city: ATTERSEE
postcode: 4864
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Austria [AT]
 Project website https://www.symptoma.com
 Total cost 2˙282˙000 €
 EC max contribution 1˙597˙400 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2018
 Duration (year-month-day) from 2018-09-01   to  2020-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SYMPTOMA GMBH AT (ATTERSEE) coordinator 1˙597˙400.00

Map

 Project objective

'OUR MISSION is to save 1.5 million lives globally each year by delivering the right diagnosis. SOCIETAL PROBLEM: To err is human. But in medicine, errors cost lives. 'The delivery of health care has proceeded for decades with a blind spot: Diagnostic errors - inaccurate or delayed diagnoses - persist throughout all settings of care and continue to harm an unacceptable number of patients.' - Institute of Medicine. Studies have shown a devastating rate of misdiagnoses ranging from 10 to 40%. Diagnostic errors cause 10% of patient deaths. 20k diseases cognitively overwhelm doctors. Only 3% of doctors are satisfied with existing research tools. Misdiagnoses account for €446 billion in wasted costs in the EU and $750 billion in the US. Solving misdiagnosis could free up 30% of total healthcare budgets globally. Patients with rare diseases suffer most. 22 of 30 million patients with rare diseases in the EU don’t have their diagnosis yet, and 8 million had to wait 10 years in average. This leaves doctors and patients with a high unmet need. SOLUTION: Symptoma.com is a free search engine for diseases. Users enter symptoms and receive a list of matching causes – sorted by probability. COMPETITIVE ADVANTAGE: Symptoma’s diagnostic accuracy has outdone all competitors’ raising the bar for this field as first and only viable solution. We have demonstrated (1) technological success, (2) high demand, and (3) willingness to pay for our solution operating at a profit with pilot customers. OUR GOAL is to improve diagnostic quality while reducing cost and time spent. We will attain this goal by pushing Symptoma to the next level by (deep) learning from search behaviour, asking questions (cognitive intelligence), and overcoming language barriers. This project is the first step towards a new paradigm of diagnostic decision making. We will fully capitalize on the business opportunity counteracting misdiagnoses for companies dealing with rare diseases.'

 Deliverables

List of deliverables.
D2.2 Release question sequences derived from deep learning algorithms. Demonstrators, pilots, prototypes 2020-01-14 16:40:45

Take a look to the deliverables list in detail:  detailed list of Symptoma deliverables.

 Publications

year authors and title journal last update
List of publications.
2019 DGIM
Querdenker-Preis
published pages: 1085-1085, ISSN: 0012-0472, DOI: 10.1055/a-0954-8989
DMW - Deutsche Medizinische Wochenschrift 144/15 2019-11-22
2019 J. Nateqi, S. Lin, H. Krobath, S. Gruarin, T. Lutz, T. Dvorak, A. Gruschina, R. Ortner
Vom Symptom zur Diagnose – Tauglichkeit von Symptom-Checkern
published pages: 334-342, ISSN: 0017-6192, DOI: 10.1007/s00106-019-0666-y
HNO 67/5 2019-11-18

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SYMPTOMA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SYMPTOMA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

LIVELMIA (2019)

Innovative assay for microRNAs analysis

Read More  

MindTrack (2019)

Analysis of eye vergence responses for the early detection and monitoring of cognitive and mental disorders

Read More  

MACCO (2019)

Bring social robots into reality with the first real world leading bartender (MACCO)

Read More